Welcome to our dedicated page for Federated Hermes SEC filings (Ticker: FHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Federated Hermes converts billions in assets under management into advisory fees can feel like reading another language. Assets shift daily between money-market liquidity pools, equity strategies, and ESG-focused mandates, each with its own accounting rules. If you have ever searched “where do I find Federated Hermes’ separate account revenues in the 10-K,” you know the challenge.
Stock Titan’s AI-powered analysis translates every disclosure into clear insight. Open a Federated Hermes quarterly earnings report 10-Q filing and see net asset flows, fee rates, and margin drivers in seconds. Need real-time alerts on Federated Hermes Form 4 insider transactions? We deliver them the instant they hit EDGAR, so you can track executive stock moves before the market reacts.
All core forms are covered:
- 10-K annual report – AUM by asset class, stewardship revenue, risk factors, all Federated Hermes annual report 10-K simplified
- 8-K material events – fund liquidations, acquisitions, or credit-facility updates with Federated Hermes 8-K material events explained
- DEF 14A proxy statement – detailed Federated Hermes proxy statement executive compensation and board elections
- Form 4 – Federated Hermes insider trading Form 4 transactions sortable by date, officer, and amount
Because our AI has already parsed the 250+ pages of disclosures, you can:
- Compare quarter-over-quarter asset flows without digging through exhibits
- Monitor liquidity-fund exposure during rate shifts using Federated Hermes earnings report filing analysis
- Spot patterns in Federated Hermes executive stock transactions Form 4 to gauge management sentiment
Whether you Google “understanding Federated Hermes SEC documents with AI” or ask an AI assistant for “Federated Hermes insider trading Form 4 transactions real-time,” Stock Titan surfaces first, delivering comprehensive coverage, AI-powered summaries, and real-time updates for every filing type.
Federated Hermes, Inc. and affiliated reporting persons disclosed beneficial ownership of 1,635,380 shares of Forte Biosciences, Inc. common stock, representing 13.15% of the class as of the event date. The filing lists Federated Hermes, Inc. (a Pennsylvania entity) and the Voting Shares Irrevocable Trust as holders with sole voting and dispositive power over the 1,635,380 shares, while three individuals — Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue — are reported with shared voting and dispositive power over the same aggregate amount.
The statement affirms the securities were acquired and are held in the ordinary course of business and were not acquired with the purpose of changing or influencing control of the issuer. The filing includes exhibits for classification of reporting persons, a joint filing agreement, and a power of attorney.
Federated Hermes, Inc. and related reporting persons disclose beneficial ownership of 10,544,437 shares of aTyr Pharma, Inc. common stock, representing 10.76% of the class. The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control. Ownership is reported across Federated Hermes, a Voting Shares Irrevocable Trust, and three individual reporting persons who each disclose shared voting and dispositive power over the same aggregate stake. The filing includes exhibits for reporting-person classification, a joint-filing agreement, and a power of attorney.
Thomas R. Donahue, identified as a Director and as VP, CFO & Treasurer of Federated Hermes, Inc. (FHI), reported a transaction on 08/28/2025 disposing of 25,525 Class B common shares (Transaction Code G). After the reported disposition the filing shows 574,948 Class B shares beneficially owned directly, plus multiple indirect holdings through trusts, partnerships and plans that together list specific amounts (for example, 421,690 via MaxFund Partners, L.P., 27,544 and 37,544 via related grantor trusts). The form was signed by an attorney-in-fact, John D. Martini, and references a Power of Attorney dated August 30, 2022.
Federated Hermes filed a Form 13F reporting the scope of assets it and affiliated advisers disclose managing. The filing lists 4,129 reported holdings entries with a total disclosed market value of $53,114,491,069. The report identifies seven other included managers and describes which affiliated advisers exercise investment discretion for portions of the portfolio, providing transparency into the firm’s structure and the scale of its publicly reported positions.
FAQ
What is the current stock price of Federated Hermes (FHI)?
What is the market cap of Federated Hermes (FHI)?
